Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0244-2021

Drug recall · February 3, 2021

Phytonadione Tablets 5mg recall

Why: Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30

Lots / codes

Lot: 18L091P, Exp 05/2021

Quantity
14,089 bottles
Company
Bausch Health Companies, Inc., Bridgewater, NJ
Distribution
Distributed Nationwide in the USA
Initiated
January 7, 2021 · Voluntary: Firm initiated
Classified
January 25, 2021
Reported
February 3, 2021
Ended
February 11, 2022
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.